SCHEMBL21282171

SCHEMBL21282171

COc1ccc(Nc2ccc3cc(I)ccc3n2)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ PABPC1 P11940 3/20 0.46
▸ PIK3CA P42336 8/20 0.45
▸ MAPK8 P45983 1/20 0.45
▸ MAPK9 P45984 1/20 0.45
▸ MAPK10 P53779 1/20 0.45
▸ FYN P06241 3/20 0.41
▸ ACP1 P24666 1/20 0.40
▸ SRC P12931 1/20 0.39
▸ USP2 O75604 2/20 0.39
▸ CDK4 P11802 1/20 0.39
▸ CCND1 P24385 1/20 0.39
▸ CDK6 Q00534 1/20 0.39
▸ PIK3CD O00329 5/20 0.38
▸ PIK3CB P42338 5/20 0.38
▸ PIK3CG P48736 5/20 0.38
▸ MAPT P10636 1/20 0.38
▸ MTOR P42345 1/20 0.38
▸ PI4KB Q9UBF8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21282159 0.86 FYN (0.49) MEN1KMT2APABPC1PIK3CAMAPK8
SCHEMBL21282210 0.86 KMT2A (0.47) MEN1KMT2APABPC1PIK3CAMAPK8
SCHEMBL21282158 0.85 FYN (0.50) MEN1KMT2APABPC1PIK3CAMAPK8
SCHEMBL21282189 0.85 MEN1 (0.46) MEN1KMT2APABPC1PIK3CAMAPK8
SCHEMBL21282214 0.81 PIK3CA (0.47) MEN1KMT2APABPC1PIK3CAMAPK8
SCHEMBL21282217 0.80 MEN1 (0.69) MEN1KMT2APABPC1PIK3CAMAPK8
SCHEMBL21282160 0.79 MAPT (0.44) MEN1KMT2APABPC1PIK3CAMAPK8
SCHEMBL21282164 0.79 PIK3CA (0.43) MEN1KMT2APABPC1PIK3CAMAPK8
SCHEMBL21282177 0.76 MEN1 (0.48) MEN1KMT2APABPC1PIK3CAMAPK8
SCHEMBL7270843 0.75 APP (0.41) KMT2ACDK4CCND1CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190256492-A1 ALPHA-SYNUCLEIN LIGANDS WASHINGTON UNIVERSITY (US) 2019-08-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256492-A1 ALPHA-SYNUCLEIN LIGANDS SNCA, PARK7, LRRK2 MEN1 4044/4885KMT2A 4633/4885PABPC1 1798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback